Kadota K - Search Results

1

Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker.

Pietanza MC, Kadota K, Huberman K, Sima CS, Fiore JJ, Sumner DK, Travis WD, Heguy A, Ginsberg MS, Holodny AI, Chan TA, Rizvi NA, Azzoli CG, Riely GJ, Kris MG, Krug LM. Pietanza MC, et al. Among authors: kadota k. Clin Cancer Res. 2012 Feb 15;18(4):1138-45. doi: 10.1158/1078-0432.CCR-11-2059. Epub 2012 Jan 6. Clin Cancer Res. 2012. PMID: 22228633 Clinical Trial.

2

Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma.

Kadota K, Suzuki K, Sima CS, Rusch VW, Adusumilli PS, Travis WD. Kadota K, et al. J Thorac Oncol. 2011 May;6(5):896-904. doi: 10.1097/JTO.0b013e318211127a. J Thorac Oncol. 2011. PMID: 21358344 Free article. Clinical Trial.

3

Prognostic immune markers in non-small cell lung cancer.

Suzuki K, Kachala SS, Kadota K, Shen R, Mo Q, Beer DG, Rusch VW, Travis WD, Adusumilli PS. Suzuki K, et al. Among authors: kadota k. Clin Cancer Res. 2011 Aug 15;17(16):5247-56. doi: 10.1158/1078-0432.CCR-10-2805. Epub 2011 Jun 9. Clin Cancer Res. 2011. PMID: 21659461 Review.

4

Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients.

Suzuki K, Kadota K, Sima CS, Sadelain M, Rusch VW, Travis WD, Adusumilli PS. Suzuki K, et al. Among authors: kadota k. Cancer Immunol Immunother. 2011 Dec;60(12):1721-8. doi: 10.1007/s00262-011-1073-8. Epub 2011 Jul 19. Cancer Immunol Immunother. 2011. PMID: 21769693 Free PMC article.

5

A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma.

Kadota K, Suzuki K, Colovos C, Sima CS, Rusch VW, Travis WD, Adusumilli PS. Kadota K, et al. Mod Pathol. 2012 Feb;25(2):260-71. doi: 10.1038/modpathol.2011.146. Epub 2011 Oct 7. Mod Pathol. 2012. PMID: 21983936 Free PMC article.

6

A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.

Kadota K, Suzuki K, Kachala SS, Zabor EC, Sima CS, Moreira AL, Yoshizawa A, Riely GJ, Rusch VW, Adusumilli PS, Travis WD. Kadota K, et al. Mod Pathol. 2012 Aug;25(8):1117-27. doi: 10.1038/modpathol.2012.58. Epub 2012 Apr 13. Mod Pathol. 2012. PMID: 22499226 Free PMC article.

7

High SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: supportive evidence to reclassify pleomorphic as nonepithelioid histology.

Kadota K, Kachala SS, Nitadori J, Suzuki K, Dunphy MP, Sima CS, Travis WD, Rusch VW, Adusumilli PS. Kadota K, et al. J Thorac Oncol. 2012 Jul;7(7):1192-7. doi: 10.1097/JTO.0b013e3182519d96. J Thorac Oncol. 2012. PMID: 22617244 Free PMC article.

8

FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.

Kadota K, Colovos C, Suzuki K, Rizk NP, Dunphy MP, Zabor EC, Sima CS, Yoshizawa A, Travis WD, Rusch VW, Adusumilli PS. Kadota K, et al. Ann Surg Oncol. 2012 Oct;19(11):3598-605. doi: 10.1245/s10434-012-2414-3. Epub 2012 May 30. Ann Surg Oncol. 2012. PMID: 22644511 Free PMC article.

9

Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma.

Kadota K, Nitadori J, Sarkaria IS, Sima CS, Jia X, Yoshizawa A, Rusch VW, Travis WD, Adusumilli PS. Kadota K, et al. Cancer. 2013 Mar 1;119(5):931-8. doi: 10.1002/cncr.27863. Epub 2012 Oct 23. Cancer. 2013. PMID: 23096929 Free PMC article.

10

Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence.

Suzuki K, Kadota K, Sima CS, Nitadori J, Rusch VW, Travis WD, Sadelain M, Adusumilli PS. Suzuki K, et al. Among authors: kadota k. J Clin Oncol. 2013 Feb 1;31(4):490-8. doi: 10.1200/JCO.2012.45.2052. Epub 2012 Dec 26. J Clin Oncol. 2013. PMID: 23269987 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,059 results

Search Page